Photobiomodulation, photomedicine, and laser surgery · 2026
Topical and Oral Photoprotection for the Treatment of Photodermatoses. A Survey of 90 Dermatologists.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Morgado-Carrasco Daniel, Delgado Jesús, Balado-Simó Pablo, Piquero-Casals Jaime
Аннотация
INTRODUCTION AND OBJECTIVES: Strict photoprotection is essential for the management of photodermatoses. However, we have not found studies on photoprotection (topical and/or oral) prescribed in clinical practice. Our objective was to describe the characteristics of topical and oral photoprotection recommended for photodermatoses, including the prescription of a topical broad-spectrum sunscreen containing ectoin (BSSE).
MATERIALS AND METHODS: An anonymous survey carried out (as a pretest) among dermatologists at an online photoprotection event held on May 20, 2023, in Spain.
RESULTS: The survey was answered by 90 dermatologists (45.4% [90/198] of the attendees). Of these, 67.8% (61/90) were women, and 83.3% (75/90) worked in public hospitals; 98.9% (89/90) reported always or almost always prescribing sunscreens in cases of photodermatoses. The most important characteristics of sunscreens were: protection against ultraviolet A (UVA) (95.6%) (86/90), against visible light (76.7%) (69/90), and the cosmetic acceptability of the product (67.8%) (61/90); 90% (81/90) reported regularly prescribing a BSSE for photodermatosis, and 60.7% (54/90) claimed that this product was effective or highly effective in reducing symptoms. Oral photoprotection was recommended by 95.5% (85/89) of respondents, and 97.7% (86/88; 2 nonresponders) reported observing a decrease in symptomatology when oral photoprotection was prescribed together with sunscreens.
LIMITATIONS: Online survey, potential inclusion bias.
CONCLUSIONS: The majority of dermatologists surveyed prescribed sunscreens with high protection against UVA and visible light for photodermatoses, recommended oral photoprotection with Polypodium leucotomos and reported observing a decrease in symptomatology after recommending topical plus oral photoprotection.
MATERIALS AND METHODS: An anonymous survey carried out (as a pretest) among dermatologists at an online photoprotection event held on May 20, 2023, in Spain.
RESULTS: The survey was answered by 90 dermatologists (45.4% [90/198] of the attendees). Of these, 67.8% (61/90) were women, and 83.3% (75/90) worked in public hospitals; 98.9% (89/90) reported always or almost always prescribing sunscreens in cases of photodermatoses. The most important characteristics of sunscreens were: protection against ultraviolet A (UVA) (95.6%) (86/90), against visible light (76.7%) (69/90), and the cosmetic acceptability of the product (67.8%) (61/90); 90% (81/90) reported regularly prescribing a BSSE for photodermatosis, and 60.7% (54/90) claimed that this product was effective or highly effective in reducing symptoms. Oral photoprotection was recommended by 95.5% (85/89) of respondents, and 97.7% (86/88; 2 nonresponders) reported observing a decrease in symptomatology when oral photoprotection was prescribed together with sunscreens.
LIMITATIONS: Online survey, potential inclusion bias.
CONCLUSIONS: The majority of dermatologists surveyed prescribed sunscreens with high protection against UVA and visible light for photodermatoses, recommended oral photoprotection with Polypodium leucotomos and reported observing a decrease in symptomatology after recommending topical plus oral photoprotection.